Amyotrophic Lateral Sclerosis Insights

Finding joy and purpose in the face of ALS

Exclusive Report

Finding joy and purpose in the face of ALS

AllMyHealth, the platform that supports rare disease communities, has written a report providing comprehensive guidance for individuals with ALS to navigate the emotional and physical challenges of the disease. It explores the psychological impact of an ALS diagnosis, effective coping strategies, and inspiring stories of individuals finding joy and purpose despite their condition. The report also covers support groups, palliative care options, the vital role of caregivers, and maintaining hope and a positive outlook.

View the Full Report

The report is available for free online on the AllMyHealth website.

www.allmyhealth.io/report

AllMyHealth Logo

Top Stories

Living Near Croplands Linked to Earlier Onset of ALS Risk

Living near croplands may increase the risk of developing amyotrophic lateral sclerosis, particularly at a younger age. Exposure to pesticides and other agricultural chemicals could be a contributing factor to this increased risk.

Read More →

Lilly Partners for New ALS Antibodies as Rivals' Candidates Struggle in Clinics

Eli Lilly has partnered to develop new antibodies for amyotrophic lateral sclerosis (ALS), while other companies' ALS treatment candidates are facing challenges in clinical trials. This collaboration aims to bring innovative therapies to patients with ALS.

Read More →

Healey ALS Trial Disappoints as Denali, AbbVie, Calico Drugs Fail

The Healey ALS trial, which included treatments from Denali, AbbVie, and Calico, has reported disappointing results, failing to show significant benefits for patients with amyotrophic lateral sclerosis. This outcome adds to the challenges in finding effective treatments for ALS.

Read More →

Latest Research

Recent studies have provided new insights into the treatment and diagnosis of amyotrophic lateral sclerosis (ALS). Li et al. (2025) are conducting a systematic review and meta-analysis to evaluate the effectiveness and safety of traditional Chinese therapies (TCT) in treating ALS, with a focus on functional and survival outcomes. Meanwhile, Akyuz et al. (2025) have identified retinal abnormalities as potential early biomarkers for ALS, utilizing retinal imaging technologies to aid in diagnosis.

In the quest for more general treatments, Faller et al. (2025) discuss the importance of targeting common disease mechanisms, such as RNA processing and inflammation, to develop broadly applicable therapeutics. These approaches aim to restore cellular homeostasis and offer hope for more effective ALS treatments.